Journey Strategic Wealth’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Journey Strategic Wealth's EXEL Position: Q1 2026 in Review
Journey Strategic Wealth reduced its Exelixis (EXEL) stake by 1.8% in Q1 2026, selling an estimated $5.59K and leaving 7,252 shares worth $311K. The position accounts for 0.01% of the portfolio, ranked #523.
Journey Strategic Wealth first reported a position in EXEL in Q2 2025 and has held it in 4 quarters since. The position peaked at $324K in Q4 2025. 701 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Journey Strategic Wealth held 7,252 shares of Exelixis worth $311K as of Q1 2026.
- Journey Strategic Wealth sold 130 Exelixis shares in Q1 2026, an estimated $5.59K.
- Exelixis made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #523 holding.
- Journey Strategic Wealth first reported a position in Exelixis in Q2 2025 and has held it in 4 quarters since.
- Journey Strategic Wealth's Exelixis position peaked at $324K in Q4 2025.
- 701 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.